Cases & Deals

GlycoVaxyn builds bioconjugate vaccine patent portfolio

Clients GlycoVaxyn AG

Jones Day represents GlycoVaxyn AG in developing its patent portfolio and prosecution strategies relating to next-generation bioconjugate vaccines, including methods for production of the vaccines using in vivo systems.